December 15, 2021
Press & Media

Exclusive Interview of PlexBio Chairman and CEO

2019.07.31

Dr Dean Tsao, chairman and CEO of PlexBio Co., Ltd.,  shares the story of his impressive expert background which led him to form the in vitro diagnostics (IVD) company in 2010. Dr. Tsao goes on to explain the company’s unique multiplexing technology based on the πCodeTM MicroDisc (‘pi-Code MicroDiscs’), and its ability to serve as a more convenient, consistent, and cost-effective alternative to next generation sequencing (NGS) in the space of precision medicine and cancer management.

For complete interview, please visit Pharma Boardroom
分享

您目前為透過後台登入模式

联络我们

偵測到您已關閉Cookie,為提供最佳體驗,建議您使用Cookie瀏覽本網站以便使用本站各項功能

Continue